This document is an excerpt from the EUR-Lex website
Document 62013CN0627
Case C-627/13: Request for a preliminary ruling from the Bundesgerichtshof (Germany) lodged on 2 December 2013 — Criminal proceedings against Miguel M.
Case C-627/13: Request for a preliminary ruling from the Bundesgerichtshof (Germany) lodged on 2 December 2013 — Criminal proceedings against Miguel M.
Case C-627/13: Request for a preliminary ruling from the Bundesgerichtshof (Germany) lodged on 2 December 2013 — Criminal proceedings against Miguel M.
OJ C 39, 8.2.2014, p. 12–13
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
8.2.2014 |
EN |
Official Journal of the European Union |
C 39/12 |
Request for a preliminary ruling from the Bundesgerichtshof (Germany) lodged on 2 December 2013 — Criminal proceedings against Miguel M.
(Case C-627/13)
2014/C 39/19
Language of the case: German
Referring court
Bundesgerichtshof
Party to the main proceedings
Miguel M.
Question referred
Are medicinal products, as defined in Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, (1) which contain scheduled substances listed in Regulations (EC) No 273/2004 (2) and (EC) No 111/2005 (3) always excluded from the scope of those regulations in accordance with Article 2(a) of both those regulations, or is that to be presumed only where the medicinal products are compounded in such a way that the scheduled substances cannot be easily used or extracted by readily applicable or economically viable means?
(2) Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004 on drug precursors (OJ 2004 L 47, p. 1).
(3) Council Regulation (EC) No 111/2005 of 22 December 2004 laying down rules for the monitoring of trade between the Community and third countries in drug precursors (OJ 2005 L 22, p. 1).